Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
To investigate the safety and efficacy recombinant human endostatin(endostar) durative transfusion combined with cocurrent chemoradiotherapy in advanced non‐small cell lung cancer(NSCLC).
Epistemonikos ID: 8d107c3f24a0d661f0d8d92efb22dc424f0dd7a9
First added on: May 21, 2024